CDNA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
CareDx Inc (CDNA) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment at this time. The technical indicators are neutral to slightly negative, options sentiment is mixed, and recent analyst ratings suggest limited upside. While the company has shown revenue growth, its profitability metrics have significantly declined, and there are no strong positive catalysts or trading signals to justify an immediate buy.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 38.965, and moving averages are converging, showing no clear trend. The stock is trading near its pivot point of 19.811, with support at 18.604 and resistance at 21.018. Overall, the technical indicators suggest a neutral to slightly bearish outlook.
Revenue growth of 20.72% YoY in Q3 2025 and an increase in gross margin to 69.36%.
Recent analyst downgrade by Craig-Hallum to Hold from Buy with concerns about future revenue and growth. No recent news or significant insider or hedge fund activity.
In Q3 2025, revenue increased to $100.055M (up 20.72% YoY), but net income dropped to $1.675M (-115.75% YoY), and EPS fell to 0.03 (-115.00% YoY). Gross margin improved to 69.36% (up 3.94% YoY).
Craig-Hallum downgraded the stock to Hold from Buy with a $26 price target, citing concerns about future revenue and growth. Wells Fargo raised the price target to $18 from $14 but maintained an Equal Weight rating. Analysts are cautious about the stock's growth potential.
